AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Caution may be the best medicine when considering misoprostol use in patients undergoing a trial of labor after a prior caesarian delivery, according to Dr. Sanchez Ramos.
He and his associate reviewed 18 cohort studies looking at the incidence of uterine rupture in patients undergoing vaginal birth after cesarean section (VBAC) who were induced with various agents (Clin. Obstet. Gynecol. 43[3]:513-23, 2000).
Patients were induced with misoprostol, oxytocin, or prostaglandin [E.sub.2] ([PGE.sub.2]). The investigators found a much higher rate of uterine rupture rupture after misprostol induction (5.4%) compared with [PGE.sub.2] induction (1.6%), oxytocin induction (1.1%), or spontaneous delivery (0.72%).
"Until more data are available regarding the safety and efficacy of misoprostoll induction in VBAC patients, its use in this setting should be restricted to research protocol," he said at the meeting.
Another recent study lends support to a cautious approach to misoprostol use and VBAC.
Misoprostol was associated with a 6% increased incidence of uterine rupture in women undergoing VBAC who were given 50 [micro]g of misoprostol, ...